MAPK3 and breast carcinoma: The study by Shao et al. showed that PLCδ1 expression was downregulated in breast cancer and that, PLCδ1 activity inhibited breast cancer cell migration via the inhibition of the ERK1/2/β-catenin/MMP pathway (Table 1).